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 Transcriptional and translational mechanisms 
contribute to regulate the expression of Discs 
Large 1 protein during different biological 
processes 
 Abstract :  Human discs large (DLG1) has been  demonstrated 
to be involved in cell polarity and maintenance of tissue 
architecture. However, the mechanisms controlling DLG1 
expression are not fully understood. This is relevant as 
DLG1 is lost during the later stages of malignant progres-
sion. We initiated a series of studies to analyse the mecha-
nisms regulating DLG1 expression. We have previously 
reported the identification of an alternative splicing event 
in the 5 ′ untranslated region (5 ′ -UTR) of DLG1 mRNA that 
generates transcripts with two different 5 ′ -UTR (short and 
large 5 ′ -UTR variants). In this study, we further examined 
the impact of the DLG1 transcription and the role of the 
differential expression of the alternative 5 ′ -UTRs on DLG1 
protein levels. We analysed these mechanisms during cell 
processes like differentiation, cell cycle progression and 
cell-cell contact formation, where the importance of DLG1 
activities was previously established. The data presented 
in this report suggest that the transcriptional regulation 
of DLG1 strongly contributes to DLG1 abundance and that 
differential expression of alternative 5 ′ -UTRs with differ-
ent translational properties, also cooperates, depending 
on the cell type and cell situation. This study provides 
new evidence for understanding the transcriptional regu-
lation of DLG1 and the changes in DLG1 expression during 
different biological processes. 
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 Introduction 
 The human discs large protein (DLG1) is an ortholog of 
DLG protein from  Drosophila (DLG-A) and belongs to the 
membrane-associated guanylate kinase family of pro-
teins whose members are characterised by the presence 
of different protein interaction modules (for a review see 
 Roberts et al., 2012 ). These interaction modules, including 
the  P SD-95/ D LG/ Z O-1 (PDZ) domains, allow the formation 
of multiprotein complexes at specialised sites of the cell, 
which are involved in functional signal transduction net-
works. In  Drosophila , DLG was demonstrated to be a key 
regulator of both cell proliferation and polarity and loss of 
DLG functions was associated with neoplastic transforma-
tion ( Bilder, 2004 ). In mammalian epithelial cells, DLG1 
localises in the cytoplasm and at sites of cell contacts, in 
association with adherens junctions ( Laprise et al., 2004 ) 
and, together with Scribble and lethal giant larvae (Lgl), 
is a component of the Scribble polarity complex, which 
is crucial for the establishment and maintenance of api-
cobasal polarity ( Assemat et  al., 2008 ). Since DLG1 was 
first detected and cloned, the mRNA was shown to be 
alternatively spliced, leading to several DLG1 isoforms 
that display different cell localisation and functions ( Lue 
et  al., 1994 ;  McLaughlin et  al., 2002 ). Moreover, DLG1 
protein was shown to be ubiquitously expressed and to 
play an important role in regulating different activities in 
a variety of cells, including epithelial cells, lymphocytes 
and neurons. 
 DLG1 interacts with several proteins including the 
phosphatase and tensin homolog (PTEN) and Adenoma-
tous polyposis coli (APC) oncosupressors, that participate 
of the control of cell proliferation ( Sotelo et  al., 2012 ). 
Moreover, these interactions were shown to be important 
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for the negative regulation of cell growth ( Ishidate et al., 
2000 ;  Valiente et al., 2005 ;  Sotelo et al., 2012 ). However, 
even though most of the observations suggest oncosup-
pression functions for the mammalian DLG ortholog, 
as it was defined in  Drosophila , there is evidence that it 
can behave like an oncoprotein according to the cellular 
context as, for example, in the presence of transforming 
viral proteins ( Frese et al., 2006 ;  Subbaiah et al., 2012 ). 
 Several reports using human biopsies have described 
changes for DLG1 expression during malignant progres-
sion ( Facciuto et al., 2012 ). While a marked reduction of 
DLG1 levels in later stages and in poorly differentiated 
tumours was described, a high overexpression and mis-
localisation of DLG1 at earlier stages of cervical, colon, 
breast and gastric cancers was observed ( Watson et  al., 
2002 ;  Boussioutas et al., 2003 ;  Cavatorta et al., 2004 ;  Fuja 
et al., 2004 ;  Gardiol et al., 2006 ). However, the contribu-
tion of this high DLG1 expression to tumour prognosis, 
the mechanisms involved in the reduction of DLG1 levels 
at more severe stages and its precise relevance, remain 
unknown. 
 Even though great progress has been achieved for the 
understanding of the post-translational modifications 
involved in the regulation of DLG1 cell localisation and 
functions ( Roberts et al., 2012 ), very little is known about 
the transcription patterns of DLG1 and its contribution to 
the control of DLG1 protein abundance in different situa-
tions. Few reports have demonstrated a down-regulation 
in DLG1 mRNA levels associated to transformation or in 
cells derived from some cancers ( Mantovani et al., 2001 ; 
 Vieira et  al., 2008 ;  Szymanowska-Narloch et  al., 2013 ). 
However, an integrated picture of the mechanism control-
ling its expression in different biological processes is not 
available, even though it would be extremely relevant, 
according to the changes in DLG1 levels observed during 
malignant progression ( Facciuto et al., 2012 ). 
 Accordingly, we initiated a series of studies to 
analyse the mechanism regulating DLG1 transcription. 
We reported previously the cloning and functional char-
acterisation of the promoter region of DGL1 and demon-
strated its regulation by the Snai1 transcription factor, 
which is involved in the epithelial mesenchymal transi-
tion ( Cavatorta et al., 2008 ). Moreover, we identified the 
presence of an alternative splicing event in the 5 ′ -UTR of 
DLG1 that generates two different transcripts: the short 
and large variants ( Figure 1 A). The exclusion of the alter-
native spliced exon in the short form increases the effi-
ciency of DLG 1 translation, indicating the participation 
of the 5 ′ -UTR in the control of DLG1 abundance ( Cavatorta 
et al., 2011 ). We showed that this event is significant in the 
regulation of DLG1 levels in transformed cells, in agree-
ment with the concept that many oncogenes and tumour 
suppressor genes express complex 5 ′ -UTRs that partici-
pate during carcinogenesis. In fact, translation initiation 
is highly sensitive to features found in the 5 ′ -UTR, like the 
presence of AUG(s) upstream of the main ORF, as iden-
tified in the large version of the 5 ′ -UTR DLG1 ( Cavatorta 
et  al., 2011 ;  Dikstein, 2012 ). The splicing identified does 
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 Figure 1:   The alternative splicing in the DLG1 5 ′ -UTR is conserved among different cell lines. 
 (A) Schematic representation of 5 ′ -UTR region of DLG1 and mRNA splice variants . The reported transcription start site is marked as  + 1 
 (GeneBank ID: U13896 and U13897). Exons containing the 5 ′ -UTR region are indicated. The DLG 5 ′ -UTR Large includes Exon A, Exon B and 
part of Exon C ( Cavatorta et al., 2011 ). In the short version of 5 ′ -UTR DLG the Exon B is absent. The length of each exon is not drawn to scale. 
(B) Total RNA of the indicated cell lines was extracted and subjected to RT-PCR as described ( Cavatorta et al., 2011 ). Both large and short 5 ′ -
UTR forms of DLG1 are shown as upper and lower bands, respectively. The cells used were: HepG2 cells (human hepatocellular carcinoma); 
SH-SY5Y cells (human neuroblastoma); Jurkat cells (human T cell leukemia); K562 cells (human myelogenous leukemia) and THP-1 cells 
(human monocyte-derived leukemia). L, DNA ladder. 
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not involve the coding region and though, the transcripts 
containing any of the 5 ′ -UTR versions should codify for 
the same protein, although with different translation effi-
ciency. However, the complete functional roles of the 5 ′ 
alternative transcripts of DLG1 were not fully elucidated 
nor their significance in different cell types. 
 In this study, we further investigated the impact of 
the transcription and the differential expression of the 
alternative 5 ′ -UTRs on DLG1 protein levels. We analysed 
these parameters during cell processes like differen-
tiation, cell cycle progression and adherence, where the 
importance of DLG1 activities and subcellular distribution 
was previously established. We demonstrated that the 
transcriptional regulation of DLG1 strongly contributes 
to DLG1 abundance and the alternative splicing event in 
the 5 ′ -UTR also cooperates, depending on the cell context. 
This report offers new evidence that contributes to the 
understanding of the pattern of DLG1 expression levels. 
 Results 
 The alternative DLG1 5 ′ -UTRs are expressed 
in cell lines from different tissues 
 Our previous analyses of DLG1 expression were mainly 
focused on epithelial cells ( Cavatorta et al., 2011 ). However, 
this protein was shown to be expressed in several tissues 
( Lue et  al., 1994 ) and many reports indicate that DLG1 
is also involved in many activities in cells such as lym-
phocytes and neurons. Therefore, we wanted to assess 
whether the alternative short and large 5 ′ -UTR formerly 
identified ( Figure 1 A) were also differentially expressed in 
cancer cells derived from diverse tissues, where the impor-
tance of DLG1 activities was previously established. We 
performed RT-PCR assays for the differential amplification 
of both DLG1 5 ′ -UTRs using RNA from A375, HepG2, Jurkat, 
SH-SY5Y, THP-1 and K562 cell lines. We included a reverse 
common primer and isoform-specific forward primers for 
each UTR, as described previously ( Cavatorta et al., 2011 ). 
As can be seen in  Figure 1 B, both large and short 5 ′ -UTR 
forms of DLG1 transcripts, shown as upper and lower 
major bands respectively, could be detected in all cell 
lines analysed, the short version being the most abundant 
variant in every case. This result indicates that the alterna-
tive splicing in the DLG1 5 ′ -UTR is conserved among the 
different cancer cell lines analysed, with potential conse-
quences on the regulation of DLG1 levels. 
 Transcription and differential expression of 
alternative 5 ′ -UTRs regulate DLG1 protein 
levels at high cell confluence 
 The DLG1 oncosuppressor represents a key component 
in the formation of adherens junctions of epithelial 
cells, whose levels increase with cell confluence, in 
agreement with the requirement of a greater number 
of cell junctions ( Mantovani et al., 2001 ). In fact, DLG1 
protein was shown to be stabilised upon increased cell 
contacts, suggesting the existence of cellular mecha-
nisms regulating DLG1 abundance in response to cell-
cell contacts. To elucidate whether the transcription 
level and the differential expression of alternative 
5 ′ -UTRs may contribute to that observation, we moni-
tored the amount of total DLG1 mRNA and of each DLG1 
5 ′ -UTR isoform, in cells growing at low and high densi-
ties. Different amounts of Caco-2 cells were plated and 
harvested for protein and RNA analysis after 24 h, at 
approximately 25% (low confluence, L) and 80% (high 
confluence, H) confluence. 
 We then performed Western blotting analysis to 
investigate protein levels and RT-qPCR assays to assess 
the total DLG1 RNA level and, specifically, the expres-
sion of each DLG1 5 ′ -UTR variant from cDNA isolated 
from cells cultured to the different densities. RT-qPCR 
analyses were performed using primers designed on 
DLG1 reading frame (present in all DLG1 messages) and 
specific primers for each 5 ′ -UTR version. Succinate dehy-
drogenase (SDH) was used as reference gene ( Cav atorta 
et al., 2011 ). 
 As can be appreciated from the results in  Figure 2 , 
DLG1 protein abundance is increased as cells become more 
confluent, as previously reported ( Figure 2 A) ( Mantovani 
et  al., 2001 ), together with a global increase of approxi-
mately three-fold in DLG1 transcription ( Figure  2 B). 
Interestingly, when assessing the amount of each 5 ′ -UTR 
isoform, both variants were increased when cell conflu-
ence was raised, yet to a different extent for each one 
( Figure 2 C). The short DLG1 5 ′ -UTR, associated to a major 
translation efficiency, was up-regulated to a higher degree 
compared to the large 5 ′ -UTR ( Figure 2 C). This is reflected 
in the increase of 5 ′ -UTR short/large ratio at high cell con-
fluence ( Figure 2 C). This result indicates that the short and 
large DLG1 5-UTRs are differentially expressed during the 
increment of the cell confluence and, in addition to gene 
transcription gain, the alternative 5 ′ -UTR splicing occurs 
at a higher frequency, most likely contributing to regulate 
DLG1 protein levels. 
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 Figure 2:   Transcription and differential expression of alternative 
5 ′ UTRs regulate DLG1 protein levels at high cell confluence. 
 Caco-2 cells were cultured at different densities and harvested 
for protein and RNA analysis at low confluence (L) or high conflu-
ence (H). (A) DLG1 protein levels are increased at high cell density. 
Protein levels were ascertained by Western blotting analysis with 
anti-DLG1 (upper panel) or anti- γ tubulin antibodies (as loading 
control, lower panel). (B) DLG1 transcription rises at high conflu-
ence. Changes in total DLG1 mRNA level were quantified by RT-qPCR 
as described in Materials and methods. DLG1 mRNA contents were 
normalised to the SDH mRNA for all samples and the relative DLG1 
mRNA amount at L was arbitrarily considered to be 1. * p  <  0.05. 
(C) The alternative splicing in the DLG1 5 ′ -UTR is increased at high 
cell confluence. Variation of each 5 ′ -UTR mRNA isoform level for 
H relative to L cell confluence (data arbitrarily considered to be 
1) is shown. For quantification of each alternative DLG1 5 ′ -UTR we 
performed RT-qPCR as described in Materials and methods. DLG1 
5 ′ -UTR mRNA contents were normalised to the SDH mRNA contents 
for all samples. Relative short/large 5 ′ -UTR mRNA fold is also shown 
for L and H cell confluence. Short/large DLG1 5 ′ -UTR mRNA at L cell 
confluence was arbitrarily considered to be 1. * p  <  0.05. In all cases, 
results are shown as mean ± SE and represent data from three inde-
pendent experiments. 
 Differential expression of DLG1 during cell 
cycle progression 
 The increase in DLG1 levels as cells reached confluence 
may be related to a restriction in cell proliferation. Actu-
ally, previous studies have also shown that DLG1 can act 
to suppress G0/G1 to S phase transition linking DLG1 func-
tion with the control of cell cycle ( Ishidate et al., 2000 ). 
Despite the relevance of this DLG1 activity, very little is 
known about the abundance of this protein during dif-
ferent phases of the cell cycle. To address this issue, we 
first synchronised Caco-2 cells by serum starvation, in 
order to obtain cell populations enriched in G0/G1 or S 
phases. We analysed the cell cycle profiles by flow cytom-
etry and confirmed that 48 h after serum deprivation most 
of the cell population was in G0/G1 and 24 h after serum 
repletion the cells were highly enriched in S phases (see 
the Materials and methods section,  Figure 3 A). In addi-
tion, the expression of the S-associated protein, cyclin E, 
was used as a control of S phase induction ( Figure 3 B). 
Once these parameters were determined, we analysed 
DLG1 expression in both populations, harvesting cells at 
the time points described above. As shown in  Figure 3 B, 
when the majority of the cells are in the S phase, there is 
a clear decrease in DLG1 protein levels when compared to 
cells largely arrested in G0/G1. This result is in agreement 
with previous data indicating that DLG1 suppresses cell 
S phase entry ( Ishidate et  al., 2000 ). We then employed 
RT-qPCR analysis to investigate the contribution of total 
DLG1 mRNA expression and as observed, the transcription 
level was significantly reduced in the S phase population 
to 2.5-fold compared to the G0/G1 group ( Figure 3 C). Then, 
considering that the pool of transcripts would be consti-
tuted by the short and large 5 ′ -UTR isoforms, we aimed to 
elucidate whether the relative proportion of these variants 
could change during the cell cycle progression, contrib-
uting to the changes in DLG1 protein abundance. We per-
formed specific RT-qPCR for each isoform and the results 
showed that entry into S phase entails a reduction in the 
levels of both transcripts at the same rate ( Figure 3 D), 
so no relevant changes in the short/large ratio were 
observed ( Figure 3 D). This would indicate that the fre-
quency of the alternative splicing in the DLG1 5 ′ -UTR 
would not be affected during the progression to the S 
phase in the cell cycle, suggesting that the changes in 
DLG1 expression related to cell proliferation induction are 
more likely regulated at the transcriptional and not the 
post-transcriptional level. 
 In agreement with this, Zimmermann et  al. have 
previously shown that the expression of Hugl-2 protein 
(human homolog to Lgl), a component of the same polar-
ity complex that DLG1, is transcriptionally regulated in 
a negative manner by inductors of cell proliferation, like 
growth factors ( Zimmermann et  al., 2008 ). Therefore, in 
order to corroborate the data presented above we evalu-
ated the effect of the addition of cell growth factors (CGF) 
on the expression of DLG1. Epithelial cells were cultured 
for 24 h in the presence of different quantities of the com-
mercial Defined Keratinocyte-SFM growth factors mix, 
as indicated in  Figure 4 A. After 24 h, RNA extracts were 
prepared and the levels of DLG1 transcripts were ascer-
tained for treated and untreated cells by RT-qPCR. As can 
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be appreciated in  Figure 4 A, the addition of CGF implies a 
significant reduction in endogenous DLG1 mRNA expres-
sion in a dose-dependent manner. 
 Next, we wanted to analyse the probable modula-
tors participating in the down-regulation of DLG1 by the 
growth factors. We previously showed that Snai1 factor 
represses DLG1 transcription and, interestingly, other 
authors demonstrated that Snai1 levels increases by 
mitogen-induced cell proliferation ( De Craene et al., 2005 ; 
 Cavatorta et al., 2008 ;  Zimmermann et al., 2008 ). Though, 
we performed RT-PCR to determine possible changes in 
Snai1 expression after treatment with the CGF. As shown 
in  Figure 4 B, the transcriptional expression of Snai1 was 
increased by the addition of the CGF and this also occurs 
in a dose-dependent manner. 
 Taken together, the overall results suggest that the 
induction of cell proliferation produce a decrease in DLG1 
expression, and this down-regulation could probably be 
mediated by an increase in the levels of Snai1 transcrip-
tion repressor. 
 Phorbol myristate acetate (PMA)-induced 
differentiation of THP-1 cells results in 
reduction of DLG1 expression 
 Previous studies have demonstrated changes in DLG1 
expression level and distribution during cell differentiation 
within squamous cervical and columnar intestinal epithe-
lium ( Watson et  al., 2002 ;  Cavatorta et  al., 2004 ;  Gardiol 
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 Figure 3:   Changes in DLG1 expression during cell proliferation induction are more likely regulated at the transcriptional level. 
 (A) FACS analysis showing cell cycle progression. The cell cycle profiles of CaCo-2 cells 48 h after serum cell deprivation (left panel) and 
24 h after serum repletion (right panel) were analysed by flow cytometry as described in Materials and methods. The approximate percent-
ages of cells in each of the major phases of the cell cycle are shown. The result is representative of three independent experiments. (B) 
DLG1 protein levels are decreased at the S phase of the cell cycle. Protein levels were ascertained by Western blotting analysis, using cells 
enriched in S or in G0/G1 phases of cell cycle, with anti-DLG1 (upper panel) or anti- γ tubulin antibodies (as loading control, lower panel). 
The expression of the S-associated protein, cyclin E, was ascertained as a control of S phase induction (middle panel). (C) DLG1 transcrip-
tion is reduced in cell S phase population. Changes in total DLG1 mRNA level were quantified by RT-qPCR as described in Materials and 
methods. DLG1 mRNA contents were normalised to the SDH mRNA for all samples and the relative DLG1 mRNA at G0/G1 phase was arbitrar-
ily considered to be 1. * p  <  0.05. (D) The alternative splicing in the DLG1 5 ′ -UTR is not affected during the induction of cell proliferation. 
Variation of each 5 ′ -UTR mRNA isoform level for S phase relative to G0/G1 phase (data arbitrarily considered to be 1) is shown. For quantifi-
cation of each alternative DLG1 5 ′ -UTR we performed RT-qPCR as described under Materials and methods. DLG1 5 ′ -UTR mRNA contents were 
normalised to the SDH mRNA contents for all samples. Relative short/large 5 ′ -UTR mRNA fold is also shown for G0/G1 and S phases of cell 
cycle. Short/large DLG1 5 ′ -UTR mRNA at G0/G1 phase was arbitrarily considered to be 1. In all cases, results were shown as mean ± SE and 
represent data from three independent experiments. 
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 Figure 4:   Growth factors negatively regulate DLG1 transcription. 
 (A) Growth factors repress expression of DLG1 transcripts in a 
dose-dependent manner. Relative expression of DLG1 mRNA, after 
treatment of epithelial cells with the indicated dilutions of CGF 
commercial supplement (GF). The transcripts were determined by 
RT-qPCR, using SDH as internal reference gene. Results were shown 
as mean ± SE and represent data from at least four independent 
experiments. * p  <  0.05. (B) The transcriptional expression of Snai1 
was increased by CGF treatment in a dose-dependent manner. Snai1 
transcription was ascertained by semi-quantitative RT-PCR, using 
RNA from epithelial untreated cells (control) or after addition of the 
indicated amount of growth factors (GF). The levels of SDH were 
analysed as a control of equivalent amounts of cDNA. 
et al., 2006 ). However, the pattern of DLG1 expression during 
differentiation was different in the two tissues. While, in 
squamous epithelium, DLG1 protein levels were reduced in 
cells of the most differentiated strata ( Watson et al., 2002 ; 
 Cavatorta et  al., 2004 ), higher expression of DLG1 was 
observed in intestinal villous cells, in comparison with less 
differentiated cells of the crypt ( Gardiol et al., 2006 ). Never-
theless, the expression of DLG1 during differentiation might 
be tissue-specific and might depend on the diverse signal 
transduction pathways involved in each biological context. 
Furthermore, little is known about the expression of this 
protein in the process of differentiation in other cell types. 
 In order to assess the importance of DLG1 expression 
during differentiation using another cell model, we chose 
the system of monocyte-to-macrophage differentiation. 
The PMA-stimulated THP-1 cell differentiation has been 
broadly used as a well-established system for the analysis 
of differentially expressed proteins ( Tsuchiya et al., 1982 ; 
 Poitz et al., 2013 ). In addition, and as shown in  Figure 1 , 
THP-1 monocyte cells expressed DLG1 mRNA and, even 
more, these cells present alternative splicing at the 5 ′ -UTR. 
 THP-1 cells were treated with PMA (10 ng/ml) for 24 h; 
within this time period the cells adhered to the cell culture 
plate and changed their morphology into a macrophage 
phenotype ( Tsuchiya et al., 1982 ). Protein and RNA were 
extracted for evaluation of DLG1 expression from cells 
harvested before and after incubation with PMA. As can be 
seen in  Figure 5 A and B, DLG1 protein and total transcrip-
tion levels decreased greatly following PMA induction. 
In differentiated cells, it was also apparent that the DLG1 
protein exhibited retarded mobility in SDS-PAGE, which 
probably reflects post-translational modification such as 
phosphorylation or different spliced isoforms ( Figure 5 A). 
However, even though both short and large 5 ′ -UTR tran-
script levels also diminished with the PMA treatment, the 
reduction was more pronounced for the short variant than 
for the large one ( Figure 5 C). Hence, relevant changes in 
the 5 ′ -UTR short/large ratio were obtained ( Figure 5 C). 
Taken together, these data indicate that during monocyte 
differentiation, DLG1 expression is reduced and this may 
be regulated by transcriptional mechanisms with the par-
ticipation of the alternative splicing in the DLG1 5 ′ -UTR 
controlling the translational efficiency. 
 Discussion 
 In this study we report new insights into transcriptional 
and post-transcriptional mechanisms that may contribute 
to control DLG1 abundance. We first wanted to address 
the question whether the identified alternative short and 
large 5 ′ -UTR isoforms ( Cavatorta et al., 2011 ) were broadly 
expressed in different cell types. We included some cells 
where the importance of DLG1 expression had previously 
been established and where no data about the possible 
mechanism of expression regulation were available. DLG1 
was shown to be a key regulator of lymphocyte prolifera-
tion and, together with other PDZ domain proteins, con-
trols lymphocyte antigen response ( Yoshida et al., 2008 ). 
In the nervous tissues, DLG1 functions as a synaptic scaf-
fold that interacts with glutamate receptors and it was 
suggested a possible association of DLG1 with neurologi-
cal disorders such as schizophrenia and autism ( Facciuto 
et al., 2012 ). DLG1 also participates in the control of the pro-
liferation of hepatocytes whose functions highly depends 
on polarisation ( Duffy et al., 2007 ). We demonstrated that 
the alternative splicing in the 5 ′ -UTR was a common and 
conserved event in all the cells analysed, with possible 
implications in the control of DLG1 abundance. However, 
these analyses were performed using cancer cells and 
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additional studies are necessary to understand the real 
impact on DLG1 protein levels in each specific cell type. 
 In epithelial cells, cell-cell adhesion induces the 
expression of DLG1 and its recruitment to the lateral 
plasma membrane at cell contacts ( Reuver and Garner, 
1998 ). The finding that cells growing with fewer mem-
brane junctions exhibit low levels of DLG1 expression 
suggested that cellular mechanism may be regulating 
DLG1 levels in response to the degree of cell confluence 
( Mantovani et al., 2001 ). This hypothesis proves interest-
ing when considering that cells from a variety of tumours 
lose the ability to form cell junctions, as well as consider-
ing the loss of DLG1 expression in undifferentiated cancers 
( Facciuto et al., 2012 ). We have shown a major increase in 
DLG1 levels in high cell density conditions and this could 
be explained by activation at the transcriptional level, 
together with an enhancement in the 5 ′ -UTR alternative 
splicing that renders a higher proportion of the short 
isoform RNA, with an upper efficiency of translation. 
These findings highlight the fact that DLG1 is subjected 
to a complex pattern of dynamic regulation when cells 
reach confluence, hinting that this protein plays an active 
role in the organisation of epithelial junctions which hold 
the cells together and that, in turn, DLG1 may negatively 
regulate cell cycle progression upon cell contact ( Ishidate 
et al., 2000 ;  Stephenson et al., 2007 ). In fact, DLG1 is able 
to interact through the PDZ domains with both APC and 
PTEN tumour suppressors with important consequences 
for cell cycle arrest, inhibition of S phase entry and reduc-
tion of proliferating signalling ( Sotelo et al., 2012 ). In this 
report we demonstrated that in agreement with this, DLG1 
is down-regulated when the S phase is stimulated and this 
may account for a decrease in DLG1 RNA level as shown 
in  Figure 3 . However, the relation between both 5 ′ -UTR 
remains unchanged during the S entry, suggesting that 
the down-regulation of DLG1 protein in this process is not 
regulated at the translational level. It is possible to specu-
late that the progression into the cell cycle promotes the 
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 Figure 5:   PMA-induced differentiation of monocytes to macrophages results in reduction of DLG1 expression. 
 (A) Protein levels were ascertained by Western blotting analysis, using THP-1 cells (monocytes, Mon) and THP-1 cells after the treatment 
with PMA (M Ø ), as described in Materials and methods. Antibodies used: anti-DLG1 (upper panel) or anti- γ tubulin antibodies (as loading 
control, lower panel). (B) The DLG1 transcription is reduced after monocyte differentiation. Changes in total DLG1 mRNA level were quanti-
fied by RT-qPCR as described in Materials and methods. DLG1 mRNA contents were normalised to the SDH mRNA for all samples and the 
relative level of DLG1 mRNA in Mon was arbitrarily considered to be 1. * p  <  0.05. (C) The alternative splicing in the DLG1 5 ′ -UTR is reduced 
during monocyte differentiation. Variation of each 5 ′ -UTR mRNA isoforms level for MØ relative to Mon (data arbitrarily considered to be 
1) is shown. For quantification of each alternative DLG1 5 ′ -UTR we performed RT-qPCR as described under Materials and methods. DLG1 
5 ′ -UTR mRNA contents were normalised to the SDH mRNA contents for all samples. Relative short/large 5 ′ -UTR mRNA fold is also shown for 
monocytes and macrophages. Short/large DLG1 5 ′ -UTR mRNA from monocyte cells was arbitrarily considered to be 1. * p  <  0.05. In all cases, 
results were shown as mean ± SE and represent data from three independent experiments. 
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synthesis or repression of different transcription factors 
that can differentially regulate the transcription of DLG1. 
In this sense the Snail family of transcription regula-
tors represses the DLG1 promoter activity by specifically 
binding to the promoter ( Cavatorta et  al., 2008 ). Snai1 
also behaves as an epidermal growth factor effector and 
probably this event may be responsible for the down-reg-
ulation of DLG1 in response to growth factors, as it was 
shown in  Figure 4 ( De Craene et al., 2005 ;  Cavatorta et al., 
2008 ). However, it is not possible to discard that other not 
yet identified mitogen-induced transcription factors can 
regulate DLG1 levels during cell cycle progression. 
 In previous studies we showed that, during epithelial 
cell differentiation, in the environment of a squamous epi-
thelium there is a clear reduction in DLG1 levels as cells 
move and differentiate towards the upper most stratus 
( Cavatorta et al., 2004 ). We wanted to extend our investi-
gations in order to analyse if this also holds true in other 
cell type models. We studied the changes in DLG1 abun-
dance for monocyte-to-macrophage transition perform-
ing the well-established differentiation model using PMA 
treatment. Monocytes are blood circulating cells and, after 
adhesion to the vessel wall, migrate into tissues and differ-
entiate into macrophages, which is an important process 
under physiological and pathological conditions. It was 
shown that other PDZ polarity proteins, such as partition-
ing defective 3 (PAR 3), are associated with monocytes 
polarised cell migration, indicating the importance of cell 
polarity proteins in the biological functions of monocytes 
( Tamehiro et  al., 2009 ). We observed that DLG1 protein 
levels decrease during monocyte-to-macrophage differ-
entiation, together with a reduction in the transcription 
level and in the 5 ′ -UTR alternative splicing rate, resulting 
in a relatively higher proportion of the large RNA isoform. 
PMA-induced differentiation correlates with increased 
nuclear translocation of NFkB, interestingly, we identi-
fied binding sites for NFkB in the DLG1 promoter region 
( Cavatorta et al., 2008 ), and it is possible to speculate that 
this contributes to the shift in DLG1 transcriptional level. 
After migration into the tissues and differentiation into 
macrophages, the cells found a hypoxic milieu; moreover, 
it was observed an increased expression of the hypoxia-
inducible factors (HIFs) after PMA stimulation ( Poitz et al., 
2013 ). HIFs have been shown to regulate the transcription 
of adhesion proteins and probably, this mechanism may 
also be implicated in the down-regulation of DLG1 during 
the monocytes differentiation ( Cheng et al., 2013 ). 
 In summary, in this report we got insight into changes 
in DLG1 levels in different biological environments. 
However, more work remains to be done and future studies 
will need to address the specific molecular mechanisms 
that regulate the 5 ′ -UTR alternative splicing and the dif-
ferent signalling pathways and downstream cross talks 
involved in DLG1 transcriptional regulation. 
 Materials and methods 
 Cell culture and antibodies 
 HEK293, HaCaT and Caco-2 epithelial cells were grown in Dulbecco ’ s 
modifi ed Eagle ’ s medium (DMEM) (Gibco, Grand Island, NY, USA). 
HepG2 cells (human hepatocellular carcinoma) and SH-SY5Y cells 
(human neuroblastoma) were grown in DMEM:Ham ’ s F12 medium. 
Jurkat cells (human T cell leukaemia), K562 cells (human myelog-
enous leukaemia) and THP-1 cells (human monocyte-derived leu-
kaemia) were grown in RPMI1640 (Gibco, Grand Island, NY, USA) 
medium. All media were supplemented with 10% (v/v) foetal bovine 
serum (FBS) (PAA Laboratories GmbH, Paschin, Austria). 
 Antibodies used were: mouse monoclonal anti-DLG1 (2D11), 
mouse monoclonal anti-cyclinE (HE12) (Santa Cruz Biotechnology, 
Dallas, TX, USA), and mouse monoclonal anti- γ tubulin (T6557) 
(Sigma Aldrich, Saint Louis, MO, USA). 
 For the analysis of cell growth factors treatment over DLG1 
expression, cells were cultured in DMEM (Gibco, Grand Island, NY, 
USA) supplemented with 5% FBS (PAA Laboratories GmbH, Pasch-
ing, Austria) and either incubated or not for 24  h previous to RNA 
extraction, with diff erent dilutions of the Defi ned Keratinocyte-SFM 
(Gibco, Grand Island, NY, USA) commercial supplement containing 
insulin, and epidermal and fi broblast grown factor (CGF). 
 RNA isolation, cDNA synthesis, RT-PCR and RT-qPCR 
 Total RNA was purifi ed using Trizol according to the manufacturer ’ s 
protocol (Invitrogen, Carlsbad, CA, USA). Synthesis of cDNA was 
obtained from 2  μ g of RNA using 200 U MMuLV RevertAid reverse 
transcriptase (Fermentas, Thermo Fisher Scientifi c, Glen Burnie, MD, 
USA) and oligo(dT) primers. For RT-PCR, each alternative DLG1 5 ′ -
UTR was specifi cally amplifi ed using diff erent sense primers as pre-
viously described ( Cavatorta et al., 2011 ) (F3, for DLG1 5 ′ -UTR large 
5 ′ -TGT CTC GGT ATG TGC GCC TT-3 ′ ; F4, for DLG1 5 ′ -UTR short, 5 ′ -TGT 
CTC GGT GTG TGC CCT CTT-3 ′ ) and a common antisense primer (R, 
5 ′ -AGC TGT CTG TCT TCA GTT TGG CT-3 ′ ). Human Snai1 transcript was 
amplifi ed using oligonucleotides: RT-hSnai1For (5 ′ -GCT GCA GGA 
CTC TAA TCC AGA GT-3 ′ ) and RT-hSnai1Rev (5 ′ -AGC CTT TCC CAC TGT 
CCT CAT CT-3 ′ ). RT-PCR was performed using 2  μ l of template cDNA, 
2.5 m m MgCl2, 0.4 m m dNTPs and 20 pmol of each primer for 27 cycles 
of 94 ° C for 40 s, 56 ° C for 40 s, and 72 ° C for 40 s. RT-qPCR analysis was 
performed using Eva Green qPCR Mezcla Real (Biodynamics, Buenos 
Aires, Argentina). For these analyses, the primers used were the same 
as described above except for DLG1 5 ′ -UTR large transcript where a 
new sense primer was designed with the following sequence: F-large, 
5 ′ -GGG CTA GGG CAA GGT GTG T-3 ′ . Furthermore, total DLG1 cDNA 
was amplifi ed using primers that target the coding region [DLG-F, 
5 ′ -CAA GCA GCC TTA GCC CTA GTG TA-3 ′ (sense), and DLG-R, 5 ′ -CAT-
GAACCAATTCTGGACCTATCA-3 ′ (antisense)]. For normalisation, the 
reference gene SDH was quantifi ed using SDH-F 5 ′ -GCA CAC CCT 
GTC CTT TGT-3 ′ (sense) and SDH-R 5 ′ -CAC AGT CAG CCT CGT TCA-3 ′ 
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(antisense) oligonucleotides. The RT-qPCR reaction conditions were 
set at 95 ° C for 5 min followed by 40 cycles of denaturation (95 ° C for 
15 s), annealing (60 ° C for 15 s) and extension (72 ° C for 20 s), with a 
single acquisition of fl uorescence levels at the end of each extension 
step. Dissociation curve analysis of amplifi cation products was per-
formed at the end of each PCR reaction to confi rm that only one PCR 
product was amplifi ed and detected. 
 Data were analysed using the threshold cycle (Ct) relative quan-
tifi cation method ( Δ Δ Ct,  Livak and Schmittgen, 2001 ). Briefl y, gene 
expression levels were normalised by the SDH reference gene. The 
relative abundance of the transcripts was calculated from 2 (- Δ Ct) , 
where  Δ Ct  =  Ct DLG1, short or large 5 ′ -UTR  – Ct SDH. Results are con-
sidered as diff erences in gene expression during the diff erent biologi-
cal processes and are expressed in relation to a given condition for 
each process. They were calculated using the 2 (- Δ Δ Ct) method. 
 Analysis of cell cycle profi les by fluorescence-activated 
cell sorting (FACS) 
 CaCo-2 cells were seeded at a density of 3  ×  10 4 cells in 60 mm dishes 
and cultured in DMEM medium containing 0.02% FBS for 48  h and 
then switched to DMEM containing 10% FBS medium and cultured for 
24 h. Cells were harvested at diff erent times aft er serum repletion and 
DNA content was assessed by propidium iodide (PI) staining and FACS 
analysis as previously described ( Darzynkiewicz et al., 2001 ). Briefl y, 
cells were fi xed in 8 ml of cold 70% ethanol in PBS, washed in PBS and 
stained with PI (PI, 50  μ g/ml of fi nal concentration). Flow cytometry 
assay was performed as previously described ( Darzynkiewicz et  al., 
2001 ) using a FACS Aria II cell sorter (Becton-Dickinson, San Jose, CA, 
USA) equipped with a 488-nm argon laser. Subsequent data analy-
sis was made employing WindMDI soft ware (Joseph Trotter, Scripps 
Research Institute, La Jolla, CA, USA). For each sample, the forward ver-
sus right-angle scatter cytogram was used to exclude debris and aggre-
gates. A minimum of 10 4 cells were analysed with linear amplifi cation 
for PI fl uorescence that was collected with a 600-nm long pass fi lter. 
Cell distribution in the diff erent phases of the cell cycle was estimated 
using CychleRed Soft ware (Terry Hoy, Cardiff  University, Cardiff , UK). 
 Western blotting 
 Western blot analyses were carried out as previously described 
( Gardiol et al., 1999 ). Briefl y, cells were harvested in E1A extraction 
buff er (250 m m NaCl, 0.1% NP40, 50 m m HEPES pH 7.0, 1 m m MgCl 2 ) 
containing Halt Protease Inhibitor single use cocktail (Thermo Sci-
entifi c Pierce, Rockford, USA). Equal amounts of proteins were sepa-
rated by SDS-PAGE and transferred to nitrocellulose. Specifi c protein 
levels were determined by immunoblot analysis using the appropri-
ate primary antibodies as indicated in the text. Blots were developed 
using the SuperSignal West Pico Chemiluminescent Substrate rea-
gent (Thermo Scientifi c Pierce, Rockford, IL, USA). 
 Phorbol myristate acetate (PMA)-induced diff erentiation 
of THP-1 cells 
 THP-1 monocytic cells (1  ×  10 6 ) were diff erentiated into macrophages 
in 60  mm dishes containing 3.5  ml of the RPMI medium in the 
presence of 10 ng/ml of PMA (Sigma, St Louis, MO, USA) over 48 h. 
Aft er incubation, nonattached cells were removed by aspiration, and 
the adherent cells (diff erentiated monocytes) were washed twice 
with PBS and harvested for RNA and protein analysis. 
 Statistical analysis 
 RT-qPCR data are shown with standard error (SE) of the mean as the 
mean ± SE and are representative for at least three independent exper-
iments. In general, statistical signifi cances were calculated using 
an unpaired two-tailed Student ’ s  t -test. The statistical signifi cance 
of the data shown in  Figure 3 F was obtained by the Scheff  é test. 
 p Values   <  0.05 were considered to be signifi cant. 
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